Trends in utilization of first-line palliative care in non-metastatic hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a ...

CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares. Historic Summer Setup: 3 "Power Patterns" Triggering in the next 75 Days - ...

Chronic vestibular migraine (CVM) is an ongoing neurological condition that causes persistent vertigo, unsteadiness, and coordination issues, in addition to severe headaches and sensitivity to light ...

CEL-SCI Corporation (NYSE:CVM) announced that the latest results from its pivotal Phase 3 study of Multikine, a presurgical cancer immunotherapy, were presented at the European Society for ...

CEL-SCI Corp. Annual cash flow by MarketWatch. View CVM net cash flow, operating cash flow, operating expenses and cash dividends.